Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case–control study

BACKGROUND: Limited therapies are available for large (≥40 mm) unresectable hepatocellular carcinoma (HCC). Currently, the standard treatment with transarterial chemoembolisation (TACE) is unsatisfactory with high recurrence rate and limited effect on survival. Laser Ablation (LA) has emerged as a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisco, Filomena, Camera, Silvia, Guarino, Maria, Tortora, Raffaella, Cossiga, Valentina, Vitiello, Anna, Cordone, Gabriella, Caporaso, Nicola, Di Costanzo, Giovan Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915130/
https://www.ncbi.nlm.nih.gov/pubmed/29707122
http://dx.doi.org/10.18632/oncotarget.24756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915130/
https://www.ncbi.nlm.nih.gov/pubmed/29707122
http://dx.doi.org/10.18632/oncotarget.24756

Ejemplares similares